These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17323498)

  • 1. Lung cancer: not just for smokers. People who never smoked may have a different form of the disease that responds better to a new generation of targeted medications.
    Harv Health Lett; 2007 Jan; 32(3):4-5. PubMed ID: 17323498
    [No Abstract]   [Full Text] [Related]  

  • 2. Autophagy facilitates the EGFR-TKI acquired resistance of non-small-cell lung cancer cells.
    Liu D; Yang Y; Zhao S
    J Formos Med Assoc; 2014 Mar; 113(3):141-2. PubMed ID: 24630031
    [No Abstract]   [Full Text] [Related]  

  • 3. Outpacing cancer.
    Dorans K
    Nat Med; 2009 Jul; 15(7):718-22. PubMed ID: 19584848
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer studies explore targeted therapy, researchers seek new prevention strategies.
    Stephenson J
    JAMA; 2002 Jun; 287(23):3063-7. PubMed ID: 12069652
    [No Abstract]   [Full Text] [Related]  

  • 5. [Molecular targeted therapy for malignant brain tumors].
    Okamura T; Kurisu K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():520-6. PubMed ID: 16201575
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance to target-based therapy and its circumvention].
    Nishio K
    Nihon Rinsho; 2004 Jul; 62(7):1343-7. PubMed ID: 15283154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the bench to the bed: individualizing treatment in non-small-cell lung cancer.
    Santarpia M; Altavilla G; Salazar F; Tarón M; Rosell R
    Clin Transl Oncol; 2006 Feb; 8(2):71-6. PubMed ID: 16632419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New therapeutic targets and strategies in lung cancer].
    Sánchez De Cos Escuín J
    Arch Bronconeumol; 2002 Aug; 38(8):386-91. PubMed ID: 12199921
    [No Abstract]   [Full Text] [Related]  

  • 9. Does hope match the hype for targeted drugs?
    Brown H
    Lancet Oncol; 2003 Aug; 4(8):452. PubMed ID: 12918521
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
    Zheng S; Jia J; Pan YL; Tao DY; Lu HS
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):42-3. PubMed ID: 23611272
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib mesylate for melanoma: will a new target be revealed?
    Grossman D
    J Invest Dermatol; 2004 Dec; 123(6):xi-xiii. PubMed ID: 15610499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in the current target therapy of malignancies].
    Stukov AN; Gershanovich ML; Filov VA; Imianitov EN
    Vopr Onkol; 2005; 51(5):607-11. PubMed ID: 16756022
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversing resistance to targeted therapy.
    Vidal L; Attard G; Kaye S; De Bono J
    J Chemother; 2004 Nov; 16 Suppl 4():7-12. PubMed ID: 15688600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.
    Launay SG; Chetaille B; Medina F; Perrot D; Nazarian S; Guiramand J; Moureau-Zabotto L; Bertucci F
    BMC Cancer; 2011 Oct; 11():423. PubMed ID: 21970335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete response after treatment with imatinib in pretreated disseminated testicular seminoma with overexpression of c-KIT.
    Pedersini R; Vattemi E; Mazzoleni G; Graiff C
    Lancet Oncol; 2007 Nov; 8(11):1039-40. PubMed ID: 17976614
    [No Abstract]   [Full Text] [Related]  

  • 16. A new KIT gene mutation in thymic cancer and a promising response to imatinib.
    Lim SH; Lee JY; Sun JM; Kim KM; Ahn JS; Ahn MJ; Park K
    J Thorac Oncol; 2013 Oct; 8(10):e91-2. PubMed ID: 24457249
    [No Abstract]   [Full Text] [Related]  

  • 17. Myeloproliferative disorders.
    Murray J
    Clin Med (Lond); 2005; 5(4):328-32. PubMed ID: 16138485
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.
    Becker JC; Muller-Tidow C; Serve H; Domschke W; Pohle T
    World J Gastroenterol; 2006 Jun; 12(21):3297-305. PubMed ID: 16733844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold standard or wrong standard?
    Oldham R; Dillman R
    Cancer Biother Radiopharm; 2004 Jun; 19(3):271-2. PubMed ID: 15285873
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.